Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma

Br J Haematol. 2012 May;157(4):494-6. doi: 10.1111/j.1365-2141.2011.09023.x. Epub 2012 Jan 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphocyte Transfusion
  • Male
  • Middle Aged
  • Multiple Myeloma / mortality
  • Multiple Myeloma / therapy*
  • Transplantation, Autologous
  • Treatment Outcome